marijuana stocks

Sipp Industries, Inc. (SIPC)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 40   191   680   701  
Cost of Revenue – 68 267 262
Gross Profit 40   124   412   439  
Operating Expenses
Research Development – – – –
Selling General and Administrative 63 85 408 430
Non Recurring – – – –
Others – – – –
Total Operating Expenses – – – –
Operating Income or Loss (23) 39   5   9  
Income from Continuing Operations
Total Other Income/Expenses Net – – – –
Earnings Before Interest And Taxes (23) 39 5 9
Interest Expense – – – –
Income Before Tax (23) 39 5 9
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (23) 39 5 9
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (23) 39   5   9  
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (23) 39   5   9  

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$ZDPY Announces Lease Amendment for Expansion at Chino Valley Property

Zoned Properties Announces Lease Amendment for Expansion at Chino Valley Property Zoned…

 The Supreme Cannabis Company, Inc. (FIRE.V) (SPRWF) 7ACRES Facility Approved for Additional Production Capacity

Supreme Cannabis’ 7ACRES Facility Approved for Additional Production Capacity 7ACRES receives Health…

$LXRP Form 10-Q

Form 10-Q for LEXARIA CORP. 14-Apr-2015 Quarterly Report Item 2. Management’s Discussion…

$CARA Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis

Cara Therapeutics Initiates Phase 2 Trial of Oral CR845 in Osteoarthritis Trial…